• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:于家乐,赵桂琴,李松涛.转铁蛋白受体功能性配体在肿瘤靶向药物递送中的应用[J].中国现代应用药学,2024,41(3):408-414.
YU Jiale,ZHAO Guiqin,LI Songtao.Application of Functional Ligands of Transferrin Receptor in Tumor Targeted Drug Delivery[J].Chin J Mod Appl Pharm(中国现代应用药学),2024,41(3):408-414.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 721次   下载 351 本文二维码信息
码上扫一扫!
分享到: 微信 更多
转铁蛋白受体功能性配体在肿瘤靶向药物递送中的应用
于家乐, 赵桂琴, 李松涛
承德医学院中药研究所,河北 承德 067000
摘要:
化疗药物由于对肿瘤缺乏选择性而产生不同程度的不良反应,其临床应用受到了一定的限制。转铁蛋白受体(transferrin receptor,TfR)在多种肿瘤细胞和肿瘤相关血管过表达,而在正常细胞低表达,是肿瘤靶向递药系统的作用靶点之一。以对TfR具有特异性高亲和作用的配体修饰药物载体或偶联抗肿瘤药物,有望实现TfR过表达肿瘤的靶向治疗。本文综述了近年来TfR功能性配体在肿瘤靶向药物递送中的应用进展,以期为TfR靶向药物递送系统的研究提供思路。
关键词:  转铁蛋白受体  功能性配体  肿瘤  靶向递药
DOI:10.13748/j.cnki.issn1007-7693.20223344
分类号:R966
基金项目:河北省高等学校科学技术研究项目(ZD2021002);河北省自然科学基金项目(H2021406058)
Application of Functional Ligands of Transferrin Receptor in Tumor Targeted Drug Delivery
YU Jiale, ZHAO Guiqin, LI Songtao
Institute of Chinese Materia Medica, Chengde Medical University, Chengde 067000, China
Abstract:
The clinical application of chemotherapeutic drugs has been limited due to the lack of tumor selectivity which causes different degrees of adverse reactions. Transferrin receptor(TfR) is one of the targets for tumor targeted drug delivery system because it is over-expressed in many kinds of tumor cells and tumor-associated blood vessels, but is low-expressed in normal cells. By modifying drug carriers or coupling antitumor drugs with ligands that have high specific affinity for TfR, it is expected to achieve targeted therapy of TfR over-expressed tumors. In this paper, the application progress of TfR functional ligands in tumor targeted drug delivery in recent years is summarized, in order to provide reference for the research of TfR targeted drug delivery systems.
Key words:  transferrin receptor  functional ligand  tumor  targeted drug delivery
扫一扫关注本刊微信